UK-headquartered start-up Tenpoint Therapeutics has reeled in a commendable $70 million in first-round financing that will be used to develop its cell-based therapies for sight-robbing diseases.

Assassin’s Creed Shadows is, quite frankly, a miraculous game. There are few franchises that have survived multiple crossings ...